Emergency Information Take Over
Friday, April 06, 2007
Dr. Robert Schwarcz is the School of Medicine's latest winner of a Board of Regents Faculty Award.
On Friday, April 13, 2007, the University System of Maryland (USM) Board of Regents will present the 2006-2007 Regents’ Faculty Awards during its spring meeting at the University of Maryland Center for Environmental Science’s Chesapeake Biological Laboratory in Solomons, MD. Seventeen USM educators and researchers will be honored for their professional accomplishments in the areas of research, scholarship and creative activity; teaching; public service; mentoring; and collaboration.
"These 17 individuals represent the pinnacle of the extraordinary talent, innovation, and dedication that make our system’s faculty among the best in the nation," said Clifford M. Kendall, chairman of the board. "We are proud of their accomplishments and very pleased to recognize them with the Regents’ Faculty Awards."
Dr. Robert Schwarcz, Professor of Psychiatry and Director of Neuroscience Research for the Maryland Psychiatric Research Center (MPRC), is the School of Medicine's honoree. Dr. Schwarcz is internationally recognized as an original and primary contributor to theory and data relating to neurodegeneration/neuroprotection, as well as being a pioneer in the study of molecular and cellular mechanisms underlying neurodegenerative and seizure disorders.
Dr. Schwarcz has made discoveries and theoretical contributions which have had significant impact on the neurosciences and have laid the foundation for important opportunities for meaningful advances in the treatment and prevention of diseases involving neurodegeneration. He has been the lead organizer for international meetings on excitotoxicity, epilepsy and the parahippocampal region and tryptophan metabolism. Schwarcz holds 37 issued patents, including both U.S. and foreign countries and eight pending patent applications for discoveries in the field of neuroprotection and cognitive enhancement. One of the patents, originally developed by Schwarcz in collaboration with Marion-Merell Dow, led to the foundation of Artemis Neuroscience, which was later incorporated into VistaGenTherapeutics, Inc., a privately held biopharmaceutical company based in Burlingame, California.
Established in 1995, the Faculty Awards are the highest honors presented to USM faculty by the Board of Regents. Awardees are selected by the Council of University System Faculty and approved by the board. Each award recipient receives $1,000 and a plaque of recognition for the honor.
For more information and details on the annual nomination process, visit the Regents’ Faculty Awards page.
University of Maryland School of Medicine
Manager, Public Affairs